(Q54289151)

27 May 2018

title

Tissue specific delivery of estrone-conjugated siRNAs. (English)

1 reference

27 May 2018

author name string

Eun-Kyoung Bang

1

1 reference

27 May 2018

Eun Mi Jeon

2

1 reference

27 May 2018

Wanil Kim

3

1 reference

27 May 2018

Kyung-Ha Lee

4

1 reference

27 May 2018

Kyong-Tai Kim

5

1 reference

27 May 2018

Byeang Hyean Kim

6

1 reference

27 May 2018

publication date

1 May 2013

1 reference

27 May 2018

published in

Molecular BioSystems

1 reference

27 May 2018

volume

9

1 reference

27 May 2018

issue

5

1 reference

27 May 2018

page(s)

974-977

1 reference

27 May 2018

Nucleic-acid therapeutics: basic principles and recent applications

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Novel phosphoramidite building blocks in synthesis and applications toward modified oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

RNA interference and chemically modified small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Biological barriers to therapy with antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

RNA interference: from basic research to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

siRNA conjugate delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Peptide conjugates of oligonucleotides: synthesis and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

17Beta-estradiol-associated stealth-liposomal delivery of anticancer gene to breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Steroid hormone receptors in breast cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

PEG conjugated VEGF siRNA for anti-angiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Reducible poly(amido ethylenimine) directed to enhance RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Cholesterol-linked fluorescent molecular beacons with enhanced cell permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Effective incorporation of 2'-O-methyl-oligoribonucleotides into liposomes and enhanced cell association through modification with thiocholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Illuminating the silence: understanding the structure and function of small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Engineering mucosal RNA interference in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Elimination pathways of systemically delivered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Lipid-based systemic delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

Estrogens and epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25258A

21 January 2018

Identifiers

DOI

10.1039/C2MB25258A

1 reference

27 May 2018

1 reference

27 May 2018